Annual Total Long Term Liabilities
$95.10 M
+$53.46 M+128.38%
31 December 2023
Summary:
Kymera Therapeutics annual total long term liabilities is currently $95.10 million, with the most recent change of +$53.46 million (+128.38%) on 31 December 2023. During the last 3 years, it has risen by +$2.43 million (+2.62%). KYMR annual total long term liabilities is now -39.25% below its all-time high of $156.54 million, reached on 31 December 2019.KYMR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$75.38 M
-$3.57 M-4.53%
30 September 2024
Summary:
Kymera Therapeutics quarterly total long term liabilities is currently $75.38 million, with the most recent change of -$3.57 million (-4.53%) on 30 September 2024. Over the past year, it has dropped by -$18.30 million (-19.53%). KYMR quarterly long term liabilities is now -51.85% below its all-time high of $156.54 million, reached on 31 December 2019.KYMR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +128.4% | -19.5% |
| 3 y3 years | +2.6% | +16.3% |
| 5 y5 years | +28.5% | - |
KYMR Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +128.4% | -25.3% | +118.7% |
| 5 y | 5 years | -39.3% | +128.4% | -51.9% | +119.2% |
| alltime | all time | -39.3% | +128.4% | -51.9% | +119.2% |
Kymera Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $75.38 M(-4.5%) |
| June 2024 | - | $78.95 M(-21.8%) |
| Mar 2024 | - | $100.91 M(+6.1%) |
| Dec 2023 | $95.10 M(+128.4%) | $95.10 M(+1.5%) |
| Sept 2023 | - | $93.68 M(+1.9%) |
| June 2023 | - | $91.92 M(+2.2%) |
| Mar 2023 | - | $89.97 M(+116.1%) |
| Dec 2022 | $41.64 M | $41.64 M(+20.8%) |
| Sept 2022 | - | $34.46 M(-9.2%) |
| June 2022 | - | $37.97 M(-17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $46.00 M(-14.4%) |
| Dec 2021 | $53.73 M(-42.0%) | $53.73 M(-17.1%) |
| Sept 2021 | - | $64.83 M(-4.1%) |
| June 2021 | - | $67.60 M(-14.6%) |
| Mar 2021 | - | $79.17 M(-14.6%) |
| Dec 2020 | $92.67 M(-40.8%) | $92.67 M(-12.1%) |
| Sept 2020 | - | $105.39 M(+206.5%) |
| June 2020 | - | $34.39 M(-78.0%) |
| Dec 2019 | $156.54 M(+111.6%) | $156.54 M |
| Dec 2018 | $73.98 M | - |
FAQ
- What is Kymera Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Kymera Therapeutics?
- What is Kymera Therapeutics annual total long term liabilities year-on-year change?
- What is Kymera Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly long term liabilities year-on-year change?
What is Kymera Therapeutics annual total long term liabilities?
The current annual total long term liabilities of KYMR is $95.10 M
What is the all time high annual total long term liabilities for Kymera Therapeutics?
Kymera Therapeutics all-time high annual total long term liabilities is $156.54 M
What is Kymera Therapeutics annual total long term liabilities year-on-year change?
Over the past year, KYMR annual total long term liabilities has changed by +$53.46 M (+128.38%)
What is Kymera Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of KYMR is $75.38 M
What is the all time high quarterly long term liabilities for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly total long term liabilities is $156.54 M
What is Kymera Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, KYMR quarterly total long term liabilities has changed by -$18.30 M (-19.53%)